Biomarker application in neonatal hypoxic ischemic encephalopathy is introduced.
S-100尾 and activin A are good markers for early diagnosis of neonatal HIE.
GFAP and UCH-L1 are promising biomarkers to predict the long-term neurologic handicap.
Optimized combination of biomarkers is proposed to enhance neonatal HIE diagnosis.